Navigation Links
An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes

clinical illness should be evaluated promptly for evidence of ketoacidosis or lactic acidosis. The reported incidence of lactic acidosis in patients receiving metformin hydrochloride is very low (approximately 0.03 cases/1000 patient-years, with approximately 0.015 fatal cases/1000 patient-years). When lactic acidosis occurs, it is fatal in approximately 50 percent of cases.

Expanding clinical development program for sitagliptin family

Merck's clinical development program for sitagliptin is robust and continues to expand with 47 studies completed or under way, and nine more studies set to begin this year. There have been more than 7,600 patients in the Company's clinical studies with about 4,700 of these patients, being treated with sitagliptin. Additionally, about 1,900 patients have been treated with sitagliptin for more than a year.

Merck's Commitment to Type 2 Diabetes

Journey for Control(TM) is Merck's comprehensive educational initiative designed to enlighten, inspire, and empower patients with diabetes by helping them make the necessary lifestyle modifications that lead to improved self-management. The program includes resources for physicians, diabetes educators, patients and health plans; all created with a focus on improving diabetes education. The Merck Journey for Control Program is proud to sponsor the U.S. Diabetes Conversation Maps, an interactive program that combines visual learning techniques and active dialogue between patients and healthcare professional to engage patients in sustainable behavior change.

The U.S. Diabetes Conversation Maps will provide physicians and diabetes educators with a uniquely powerful way to engage patients in conversations to help support behavior changes that can make a critical difference in treatment outcomes. Content for the U.S. Diabetes Conversation Map was developed and reviewed by the ADA and the program was launched in June at the ADA 67th Annual Scientific Sessions in Chicago
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
3. Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
4. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
5. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
6. Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
7. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
8. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
9. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
10. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents
11. Investigational Study Evaluates the Effectiveness of Aripiprazole in Adolescents With Schizophrenia
Post Your Comments:
(Date:11/21/2014)... Nov. 21, 2014  Lexicon Pharmaceuticals, Inc. (Nasdaq: ... previously announced underwritten public offering of $50,000,000 of shares ... registration statement. The offering will consist of 49,751,244 shares ... $1.005 per share.  Lexicon has also granted the underwriters ... shares of common stock.  All of the shares in ...
(Date:11/18/2014)... MOUNT LAUREL, N.J. , Nov. 18, 2014 ... more than 230,000 American women this year who ... Manager Certification® today announced new resources for case ... cancer—stages 4 and 5—to navigate the myriad physical, ... territory. The resources are available at no cost ...
(Date:11/18/2014)... , Nov. 18, 2014 SynCardia Systems, ... the Year Award for Small Companies presented by the ... Authority. The 11th annual Governor,s Celebration of ... Arizona . Arizona ... the awards ceremony. SynCardia was honored for its Freedom® ...
Breaking Medicine Technology:Lexicon Announces Pricing Of Common Stock Offering 2Lexicon Announces Pricing Of Common Stock Offering 3New Breast Cancer Resources: Commission For Case Manager Certification Adds Specialty Tools to Case Management Body of Knowledge Online Learning Center 2SynCardia Named Innovator of the Year by the 2014 Governor's Celebration of Innovation Awards for Its Freedom Portable Driver 2SynCardia Named Innovator of the Year by the 2014 Governor's Celebration of Innovation Awards for Its Freedom Portable Driver 3
(Date:11/21/2014)... (PRWEB) November 21, 2014 Porcelain ... picture-perfect smiles for patients in preparation for the coming ... the fronts of teeth, look completely natural, and can ... situations, veneers are also valued for their ability to ... and can be used on one or several teeth ...
(Date:11/21/2014)... 20, 2014 (HealthDay News) -- Seeking to make it ... Food and Drug Administration on Thursday approved a new ... Hydrocodone -- best known by the brand name Vicodin ... tied to a surge in dangerous addictions across the ... Hysingla ER (hydrocodone bitartrate) is an extended-release tablet to ...
(Date:11/21/2014)... 20, 2014 (HealthDay News) -- Certain genes might prevent ... to a fifth of people with type 2 diabetes, ... been pondered by doctors working with diabetic patients, one ... under the impression that exercise helps decrease insulin resistance ... Pena, director of the Center for Weight Management at ...
(Date:11/21/2014)... 21, 2014 Richard Wolfe, co-founder ... will present advanced benefits administration strategies during the ... HR Leadership Summit. This Game Changer breakout session ... to present cutting-edge solutions and best practices to ... how real-time data exchange between health and welfare ...
(Date:11/21/2014)... (PRWEB) November 21, 2014 Center for ... workshops titled “Massachusetts Insurance Funding for Autism Workshops” to ... navigate their way through the insurance coverage process. ... Massachusetts law and the most effective ways to access ... Dec. 4 from 6-8:00 p.m. at 331 Montvale Ave., ...
Breaking Medicine News(10 mins):Health News:Los Angeles Porcelain Veneers Dentist, Dr. Kevin Sands, Now Creates Picture-Perfect Smiles for Patients for the Holiday Season 2Health News:FDA Approves 'Abuse-Resistant' Narcotic Painkiller 2Health News:FDA Approves 'Abuse-Resistant' Narcotic Painkiller 3Health News:Exercise Might Not Help Some Type 2 Diabetics Control Their Blood Sugar 2Health News:Exercise Might Not Help Some Type 2 Diabetics Control Their Blood Sugar 3Health News:Empyrean Benefit Solutions CEO Sharing Latest Benefits Administration Strategies with Houston HR Leaders 2Health News:Empyrean Benefit Solutions CEO Sharing Latest Benefits Administration Strategies with Houston HR Leaders 3Health News:Center for Autism and Related Disorders to Host Massachusetts Autism Insurance Workshops for Parents 2
... tests for liver fibrosis, such as liver stiffness measurement ... chronic hepatitis C, according to a new study in ... Gastroenterological Association (AGA) Institute. "Liver stiffness measurement ... evaluation of hepatitis C, regardless of the stage of ...
... 2020 strategy and its Innovation Union flagship initiative, the ... cooperation activities and how EUREKA could contribute to strengthening ... in the regions. High-level stakeholders and all interested ... conference,s discussions which will have a significant role in ...
... HealthDay Reporter , MONDAY, June 13 (HealthDay News) ... even though most people agree the government-sponsored health insurance program ... survive. Instead, respondents to a Harris ... should be shored up, in part, by lowering the fees ...
... sleep problems with cognitive-behavioral therapy for insomnia can reduce ... presented Tuesday, June 14, in Minneapolis, Minn., at SLEEP ... Sleep Societies LLC (APSS). Results show that about ... reported having suicidal thoughts or wishes during the past ...
... sleep per night is associated with higher ratings for quality ... abstract that will be presented Tuesday, June 14, in Minneapolis, ... Associated Professional Sleep Societies LLC (APSS). Results show that ... hours per night had higher self-reported scores for quality of ...
... By Randy Dotinga HealthDay Reporter , MONDAY, June ... help children solve problems more easily, a goal that can ... study suggests. The research doesn,t suggest that ordinary video ... how a particular type of training can boost brain skills ...
Cached Medicine News:Health News:Noninvasive liver tests may predict hepatitis C patient survival 2Health News:Poll Finds Little Support for GOP Plan to Privatize Medicare 2Health News:Poll Finds Little Support for GOP Plan to Privatize Medicare 3Health News:Cognitive-behavioral therapy for insomnia can reduce suicidal ideation 2Health News:The good life: Good sleepers have better quality of life and less depression 2Health News:Training via Video Game Shown to Boost Kids' Brain Power 2Health News:Training via Video Game Shown to Boost Kids' Brain Power 3
Bacterial/Viral Filters for Anesthesia and Respiratory Applications...
Bacterial/Viral Filters for Anesthesia and Respiratory Applications...
Ballard trach care HMES and filters, universal use, "Y" filter, CO 2 sampling port...
Indications For Usage: ,Single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to be replaced at least once every 24 hours...
Medicine Products: